Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria, Plasmodium Falciparum”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00330902
What this trial is testing

Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan

Who this might be right for
Plasmodium Infections
London School of Hygiene and Tropical Medicine 104
Large-scale testing (Phase 3)Study completedNCT01365598
What this trial is testing

Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda

Who this might be right for
Falciparum Malaria
London School of Hygiene and Tropical Medicine 468
Testing effectiveness (Phase 2)Ended earlyNCT00988507
What this trial is testing

Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Infection
Sanofi 440
Testing effectiveness (Phase 2)WithdrawnNCT01002183
What this trial is testing

Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate

Who this might be right for
Malaria
Jomaa Pharma GmbH 40
Early research (Phase 1)Study completedNCT02614404
What this trial is testing

Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
HuLow 15
Not applicableEnded earlyNCT00497471
What this trial is testing

RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants

Who this might be right for
MalariaAnemia
Hospital Clinic of Barcelona 832
Testing effectiveness (Phase 2)Study completedNCT05978037
What this trial is testing

Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines

Who this might be right for
MalariaMalaria,FalciparumParasitic Disease+2 more
University of Oxford 41
Early research (Phase 1)Study completedNCT01026246
What this trial is testing

EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT01240603
What this trial is testing

Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern Cambodia

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 415
Post-approval studies (Phase 4)Study completedNCT00233337
What this trial is testing

Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers

Who this might be right for
Acute Uncomplicated P. Falciparum Malaria
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01524341
What this trial is testing

Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection

Who this might be right for
Malaria
Novartis Pharmaceuticals 27
Early research (Phase 1)Not Yet RecruitingNCT06293339
What this trial is testing

Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge)

Who this might be right for
Malaria,Falciparum
Leiden University Medical Center 14
Not applicableLooking for participantsNCT07389057
What this trial is testing

Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

Who this might be right for
Malaria Asymptomatic ParasitaemiaMalaria FalciparumMalaria Infection+1 more
Noguchi Memorial Institute for Medical Research 9,000
Early research (Phase 1)Study completedNCT03589794
What this trial is testing

RCSP/AP10-602 [GLA-LSQ] Vaccine Trial

Who this might be right for
Plasmodium Falciparum Infection
National Institute of Allergy and Infectious Diseases (NIAID) 65
Post-approval studies (Phase 4)Study completedNCT00808951
What this trial is testing

In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso

Who this might be right for
Malaria
Centre Muraz 440
Early research (Phase 1)Study completedNCT04318002
What this trial is testing

Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania

Who this might be right for
Malaria,Falciparum
University of Oxford 60
Post-approval studies (Phase 4)Study completedNCT00146796
What this trial is testing

A Randomised Trial of Rapid Diagnostic Tests in the Diagnosis of Malaria in Tanzania

Who this might be right for
MalariaFebrile Illness
London School of Hygiene and Tropical Medicine 2,400
Early research (Phase 1)Looking for participantsNCT06862453
What this trial is testing

Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults

Who this might be right for
Malaria Falciparum
Sanaria Inc. 58
Early research (Phase 1)Study completedNCT00340574
What this trial is testing

Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)

Who this might be right for
Healthy VolunteerHV
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00316329
What this trial is testing

ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Malaria
Sanofi 1,032
Next Page